» Articles » PMID: 27364550

Imaging of Esophageal Lymph Node Metastases by Desorption Electrospray Ionization Mass Spectrometry

Overview
Journal Cancer Res
Specialty Oncology
Date 2016 Jul 2
PMID 27364550
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Histopathological assessment of lymph node metastases (LNM) depends on subjective analysis of cellular morphology with inter-/intraobserver variability. In this study, LNM from esophageal adenocarcinoma was objectively detected using desorption electrospray ionization-mass spectrometry imaging (DESI-MSI). Ninety lymph nodes (LN) and their primary tumor biopsies from 11 esophago-gastrectomy specimens were examined and analyzed by DESI-MSI. Images from mass spectrometry and corresponding histology were coregistered and analyzed using multivariate statistical tools. The MSIs revealed consistent lipidomic profiles of individual tissue types found within LNs. Spatial mapping of the profiles showed identical distribution patterns as per the tissue types in matched IHC images. Lipidomic profile comparisons of LNM versus the primary tumor revealed a close association in contrast to benign LN tissue types. This similarity was used for the objective prediction of LNM in mass spectrometry images utilizing the average lipidomic profile of esophageal adenocarcinoma. The multivariate statistical algorithm developed for LNM identification demonstrated a sensitivity, specificity, positive predictive value, and negative predictive value of 89.5%, 100%, 100%, and 97.2%, respectively, when compared with gold-standard IHC. DESI-MSI has the potential to be a diagnostic tool for perioperative identification of LNM and compares favorably with techniques currently used by histopathology experts. Cancer Res; 76(19); 5647-56. ©2016 AACR.

Citing Articles

Lipid metabolism analysis in esophageal cancer and associated drug discovery.

Jiao R, Jiang W, Xu K, Luo Q, Wang L, Zhao C J Pharm Anal. 2024; 14(1):1-15.

PMID: 38352954 PMC: 10859535. DOI: 10.1016/j.jpha.2023.08.019.


Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging.

Mao X, Huang L, Li T, Abliz Z, He J, Chen J Molecules. 2023; 28(15).

PMID: 37570761 PMC: 10421042. DOI: 10.3390/molecules28155791.


Direct Liquid Extraction and Ionization Techniques for Understanding Multimolecular Environments in Biological Systems (Secondary Publication).

Otsuka Y Mass Spectrom (Tokyo). 2021; 10(1):A0095.

PMID: 34249586 PMC: 8246329. DOI: 10.5702/massspectrometry.A0095.


Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology.

Patel S, George B, Rai V Front Pharmacol. 2020; 11:1177.

PMID: 32903628 PMC: 7438594. DOI: 10.3389/fphar.2020.01177.


Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Holzlechner M, Eugenin E, Prideaux B Cancer Rep (Hoboken). 2020; 2(6):e1229.

PMID: 32729258 PMC: 7941519. DOI: 10.1002/cnr2.1229.